Every study recruiting in India, live from the public registry.
A catalogue of ClinicalTrials.gov records with a site in India, filtered by state, condition, phase and status, with the rest of the world one chip away.
- 609recruiting in India today
- 766open or opening soon in India
- 64,584recruiting worldwide
- The registry’s own counts, refreshed hourly.
Know the trial number?
Enter an NCT number, or the sponsor’s protocol number from a consent form or study letter. EudraCT, EU CT and CTRI numbers work when the sponsor listed them on the record.
Showing 23 of 609 studies recruiting in India.
Public records · ClinicalTrials.gov · recently updated first
- Phase 3RecruitingStarted Jan 2026
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Severe Asthma
Vadodara, Nagpur
SponsorGenerate Biomedicines2sites in India - Phase 3RecruitingStarted May 2026
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Hubli, Hyderabad, Jaipur, Kochi +4 more
SponsorJanssen Research & Development, LLC8sites in India - Phase 3RecruitingStarted Oct 2025
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Mania · Bipolar Disorder
Madurai, Kolkata, Mangalore +1 more
SponsorBristol-Myers Squibb4sites in India - Phase not statedRecruitingStarted Jun 2026
Coordinated Care for Alcohol Problems
Alcohol Use Disorder
Goa
SponsorSangath1site in India - Phase 3RecruitingStarted Dec 2021
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Carcinoma, Squamous Cell
Bangalore, Mumbai, Nashik, New Delhi +1 more
SponsorJohnson & Johnson Enterprise Innovation Inc.5sites in India - Phase 3RecruitingStarted May 2026
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Hubli, Hyderabad, Jaipur, Kochi +4 more
SponsorJanssen Research & Development, LLC8sites in India - Phase 2RecruitingStarted Oct 2025
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Bangalore, Bengaluru, Bhubaneswar, Gurugram +15 more
SponsorJanssen Research & Development, LLC19sites in India - Phase 3RecruitingStarted May 2026
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Chhatrapati Sambhajinagar, Pune, Rishikesh, Kolkata +1 more
SponsorNovartis Pharmaceuticals5sites in India - Phase 3RecruitingStarted May 2023
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Major Depressive Disorder
Bārāmati, Bikaner, Chandigarh, Kolhāpur +3 more
SponsorIntra-Cellular Therapies, Inc.7sites in India - Phase 3RecruitingStarted Oct 2024
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Delhi, Kolkata, Mumbai, Pune +1 more
SponsorJanssen Research & Development, LLC5sites in India - Phase 3RecruitingStarted Dec 2025
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Chennai, Jaipur, Kolkata, Nashik +2 more
SponsorJanssen Research & Development, LLC6sites in India - Phase not statedRecruitingStarted Sep 2026
A Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent Study
Adjunct in the Treatment of Depressive Disorder
Vadodara
SponsorSichuan Credit Pharmaceutical Co., Ltd.1site in India - Phase 3RecruitingStarted Dec 2024
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Delhi, Hyderabad, Kolkata, Mumbai +4 more
SponsorJanssen Research & Development, LLC8sites in India - Phase 3RecruitingStarted Oct 2026
A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
Hyperlipidemia · Hypercholesterolemia
Belagavi, New Delhi
SponsorMerck Sharp & Dohme LLC2sites in India - Phase 3RecruitingStarted Oct 2026
A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through Menopause
Hot Flashes
Bengaluru
SponsorAstellas Pharma Inc1site in India - Phase 3RecruitingStarted Sep 2022
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Ahmedabad, Gurugram, Belagavi, Mumbai +2 more
SponsorCelgene6sites in India - Phase not statedRecruitingStarted Jul 2025
Capella Scientia Development Study
Cataract
Bangalore
SponsorAlcon Research1site in India - Phase 2RecruitingStarted Mar 2025
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Belagavi, Coimbatore, Dehradun, Delhi +2 more
SponsorAstraZeneca6sites in India - Phase not statedRecruitingStarted May 2025
A Clinical Trial to Study the Effects on the Olfaction Capacity of an Individual Undergoing Skull Base Surgeries Using Cautery vs Scalpel .
Olfaction
Jodhpur
SponsorAll India Institute of Medical Sciences, Jodhpur1site in India - Phase not statedRecruitingStarted May 2025
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Age-Related Macular Degeneration
Chennai +1 more
SponsorUniversity of Wisconsin, Madison2sites in India - Phase 2RecruitingStarted Dec 2020
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer
Ahemdabad, Ahmedabad, Bangalore, Belagavi +15 more
SponsorMirati Therapeutics Inc.19sites in India - Phase not statedRecruitingStarted Sep 2025
Effect of Menstrual Phase on the Anesthetic Efficacy
Pulpitis - Irreversible
New Delhi
SponsorJamia Millia Islamia1site in India - Phase 3RecruitingStarted Aug 2026
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Coimbatore, Hyderabad, Indore, Jaipur +8 more
SponsorAstraZeneca12sites in India
Every study above is a public record from ClinicalTrials.gov, run by the sponsor and sites named on it. Each study’s research team decides who can take part, and Trialion takes no payment for referrals. Studies registered only with CTRI are not included. Site counts leave out sites the record marks as suspended or closed. A location filter finds records where the site typed that place in, so a study can be running near you and not appear here.
What this is
A public register, made readable.
01
Public records, live
Every card is a ClinicalTrials.gov entry, fetched from the registry and refreshed every fifteen minutes. Nothing is typed in by hand.
02
Run by their sponsors
Each record names the sponsor and sites that run the study, and their research team decides who can take part. Trialion takes no payment for referrals.
03
Take the number to a doctor
An NCT number links back to the registry entry with its sites and ethics approvals. A doctor can say whether a study is worth approaching.

Running one of these?
Keep the data behind your study on one record
The EDC drafts the forms from your protocol, reads the lab reports and holds every change on one audit trail. Bring the protocol and see it running.
Book a demo